{"name":"Integra LifeSciences","slug":"integra","ticker":"IART","exchange":"NASDAQ","domain":"integralife.com","description":"Integra LifeSciences Holdings Corporation is a global medical device manufacturing company headquartered in Princeton, New Jersey. Founded in 1989, the company manufactures products for skin regeneration, neurosurgery, reconstructive and general surgery. Integra artificial skin became the first commercially reproducible skin tissue used to treat severe burns and other skin wounds.","hq":"Princeton, NJ","founded":0,"employees":"4427","ceo":"Stuart Essig","sector":"Regenerative Medicine / Neurosurgery","stockPrice":9.94,"stockChange":0.61,"stockChangePercent":6.54,"marketCap":"$775M","metrics":{"revenue":1635245000,"revenueGrowth":-1.7,"grossMargin":56.2,"rdSpend":78041000,"netIncome":-516474000,"cash":263740992,"dividendYield":0,"peRatio":3.9,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"DuraGen Dural Regeneration Matrix patent cliff ($100M at risk)","drug":"DuraGen Dural Regeneration Matrix","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Integra LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Integra LifeSciences reported fourth quarter and full year 2023 financial results, with revenue of $444.8 million and $1.7 billion, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-11-16","type":"deal","headline":"Integra LifeSciences Announces Agreement to Acquire Orthofix's Spine and Biologics Business","summary":"Integra LifeSciences announced an agreement to acquire Orthofix's spine and biologics business for $300 million.","drugName":"","sentiment":"positive"},{"date":"2023-08-29","type":"regulatory","headline":"FDA Approves Integra LifeSciences' DuraGen Dural Regeneration Matrix","summary":"The FDA approved Integra LifeSciences' DuraGen Dural Regeneration Matrix for use in dural repair and reconstruction.","drugName":"","sentiment":"positive"}],"realNews":[{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQaWpDZUN5RExXVWUzTjJZVE9fR0Q5d3FQbTN4VGdKME50anJudExWMXNSMXdfR25OOVNuakdYT2JRblg5RWZpQlpwSV9DYU9wS2dtUS1LNG5lNzN4YWxSWlBzXzgtVzRSLVYxbTRQN3pkdXdJQkdXaTZzXzFrekpEMzlkZXRGU2o4bTEzMjZEd1pOMk9OYVFheWEtTTdYaHdma1Q1U0xZbmxSajM2ZnZnRHd1emxMZkFuR3doUkUybVY2LWxVM1lSRmxPd1NfNlEwRmNxdXd2VS1NMmZ2MWdkQlI0dTNnaGtoeG9PcllBY0U4b2hJaEdYOGI2ZjFEX1dYT0VUTFpXa3p5SE95VWI2cTNYT05MUQ?oc=5","date":"2026-02-21","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART) and Travere Therapeutics (TVTX) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Integra Lifesciences (IART) and Travere Therapeutics (TVTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQbkZvT2hvUm1XMXZDRUNUTy15Tk4tWkYxc3F6SlZ0MDJ4aEJaRk52YTctcGl6SzVEbUVpdThqNnBOVU1iVjcxTE5vSjlac0VrWWNyZ0NRei04U0pqRUFoOWUxZTNrRlZKUEFCcjlPNEtyY094bGYtX1dUM3hydjQyUXhwak1lZXpUM1JuOW1fdkxsWXdfZ055ZXU3T21NQ042c2FxenFYRXlCdjN1UjFRcg?oc=5","date":"2026-02-17","type":"pipeline","source":"Stock Titan","summary":"New tech and quality chiefs signal Integra’s next growth push - Stock Titan","headline":"New tech and quality chiefs signal Integra’s next growth push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPaG5Ra0ZzbjlfTDVOVUU3ZTZZbkJrRjBXRHJDT2pDcVlZNmZNVm03bEtIMm41ejZxVGM0MEduY2xRVVl3X1FlT2xaelZFVk5RYXlsbmFIeHBXVkZRM2FVX0pBSFZkYXp1Zm1PU1pIcC16cmdxV2h1T0Y2eF9IWGRRWnZUU0JtelA5bE1vMjNhdW13SHRmQTNpWkJHMnRFdw?oc=5","date":"2026-02-13","type":"pipeline","source":"Yahoo Finance","summary":"Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance","headline":"Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOaEZJUl8yQWJDS3N1UTNGQk9UM1FuN2FJbk45UXFDMVdVems1ekVxbFppekJMRmstNDlBeDBpOHE5MEFyTnhrRHEteTdIcWNEeG1VS29qV2RWRE5MOS1iMzV1c2I4Q0pZS1dsOGpmYWV4Zm5VaVpwQW54MjdzWXN3cjE1UE1PRjZzdHBwbjAyejJGeFJicGloQWZzTktGd3hQVjhadnJTbEowbXVMOG9NNDE0c0NWeS1IWTE5N1RaSndoRFliYndqWFJuMmk1bmV2NkhKb08tWUlSTHFiMjlhbHlzRzBUU241UWg5TDhCdE1nLWEybENvekZRYWUyc0pzY3Z1Ulh3emNmOHB1ZE5kY0d5VFQ0c1JjeTZ6eG9nSnhHUk42cjU0Y0F5LXRwdw?oc=5","date":"2026-02-13","type":"pipeline","source":"The Globe and Mail","summary":"Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need To Know - The Globe and Mail","headline":"Moderna, Vertex Pharmaceuticals, Integra LifeSciences, Baxter, and Molina Healthcare Shares Are Soaring, What You Need T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQQVVsQ1lwNUxyenI5VXFqWmk1TVYtM1N2TnJPN1RTWWZjSVFNWXBVX0E3VGRGR1pYV3RNSHFMdi1rZEZwem5DVVR4Z1V6eWVYdkc5LVZvODZacm0wX0VEaDI3VWZ5YnAwYlJOUC1WdlBUQklEMkZOTVFOS3pEaXFXeG9mLTFlNWd4ZGFxTkhSRHJ5R3NiSE9qbTA3cFRCY0YzNmd1MVFJTXpQejhGb3RhRw?oc=5","date":"2025-12-18","type":"pipeline","source":"Seeking Alpha","summary":"Integra LifeSciences: Potential Only Takes You So Far Without Execution (NASDAQ:IART) - Seeking Alpha","headline":"Integra LifeSciences: Potential Only Takes You So Far Without Execution (NASDAQ:IART)","sentiment":"neutral"},{"date":"2025-12-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNRFBhc0FtVzlNaERsbDM5U1N5X2NkWUdGck9MVkptRFZZTDZldGdkTVdyT3ZHZF9pWUh4aERlbUEya0x6NDZGdndFcWhiVWVLVllfRVZMLUpaX3NMZVJSOWRpX0ZWY01MTFI4eS1xX3dpUmZDUm12RDBVUEZNOWgwQUpiRmQ2b0d4RDlVcXd3TTBvT0tfRk5oOVVLYTdqMGRQRXktWTdoaVZEZXpibjc5V0JWZTNZYlk3VGVzR1JkVEZFYnJpVUZCRkV4RktpUkpVRXY0MWVHaXNGV19SNjQ0NVRKbk9aLVluOTZoeXBaNnNacnplSThzSjNWSURBU3hpOUM0QmJBbm5MZ1MxYnRMZ3lxRWE1UQ?oc=5","date":"2025-10-10","type":"pipeline","source":"StockStory","summary":"Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Need To Know - StockStory","headline":"Integra LifeSciences, Inspire Medical Systems, Merit Medical Systems, Enovis, and CONMED Shares Are Falling, What You Ne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQZm02MWJJSWFjLXFSM3NlTHI0RkVmNW5ab1E2eEdDQmpNY3E2b1BsdFZNRF9YcTJhanE2UUJIejVtTWhNaGQ1bUoybUlLYTZUeUdfMXhPTTZWc3VqaDhfN0ZJUm5ydUt2aE0wYzEzY3RVc0VLbW1qVWRaYmxWaDhNZGJBUzhlWXdWamNPSk5UUWNnNWZtN0RVbDl2MXVpVUFrTHJsUVFvZ0Y?oc=5","date":"2025-09-10","type":"pipeline","source":"Seeking Alpha","summary":"Integra LifeSciences Still Recovering From Self-Inflicted Wounds (NASDAQ:IART) - Seeking Alpha","headline":"Integra LifeSciences Still Recovering From Self-Inflicted Wounds (NASDAQ:IART)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxPV2N5dlV2alE2eGZHcU5BYXRtZUNERkZ0ektQSU1fZFlUNVBBdDZwQ3R0N053UkJqWURHc05jUXJQNmdkUTZXTTNDSmZDaEdKWWp1QjZYZjVyRU56ZWJQOGZkaFE2SVp3S19aUjk0U3doTkR4cnp0TVFQTTFDVkI3SFVCc2NBQzRFc3NLT21uUlR5V2pwVHRBVW9lUEoyYXpMeUtsUXZMa2ZYY1JkbzFnei0taV9YM19YNlNWdDh4TFFLdjFXdGVtUHZYb1dwSC1meE91VjZMdWdpeTBJM0pldnhQYTRCTWg5aUxFQlJsWWxTTG9sNWZMYXZlRXlSMVJjNVlmZkxKdkpaVk9yNUc2WUNkTDh2QQ?oc=5","date":"2025-08-12","type":"pipeline","source":"StockStory","summary":"Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know - StockStory","headline":"Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Ne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOb3VKbURnMUo1RDBkX2c2N2ZSaFdrQWduMHNwYXBMaHBBWVpXcTRXaGVCTTFzVnYzbWtBWndxanNURXVUQ0g5M1U0OEsxQ2t3RVRmLXl1aUY2QkZrVzBHbHY4ZUNWSndRbS1TTVJ1Wm5HRUVscHRkb3lLLWxLQUdHRkUtQVJLWnBUVzJpM2E2S2FWVTl4aWNFWk8ySUpuUjN0UlROazc2TVVhTEJjRkZ0MXBad3RZSkJpcjFPN3l3?oc=5","date":"2025-04-18","type":"earnings","source":"Stock Titan","summary":"Integra LifeSciences Earnings Preview: Medical Tech Giant Sets Q1 2025 Results Date for May 5 - Stock Titan","headline":"Integra LifeSciences Earnings Preview: Medical Tech Giant Sets Q1 2025 Results Date for May 5","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQb2dFaWladVhLUi1DNDYzbFRZSmY3WDhrcnVvdWN6SWR2aTg2RHNjTF9fUF93UUphb0FfdGJwQXhOWVllZUNINmpUMXNSU1lEMXY4b2NTMVNSR1Y2bGJ3RER0blFnaHRfR0doSHEybGVNc1ZCX0hjTS1nLVlFSWROVV92SG9PSDNFVno3b2RDM3JuMFF4eVJXUVNPYXhkZG5aX2loeEVHSlIycUtGRjFHUHpnTjJmWERMQ1dkQWpfckVsUHFPelVWblE3SEhzN093bUY5VVRmbmRIYklNTkhZ?oc=5","date":"2024-04-02","type":"pipeline","source":"BioPharma APAC","summary":"Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions - BioPharma APAC","headline":"Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQWURpTzdiS0ItWkNtWUVqVkUtdVE5UGNnSDQzLUNMdHh4bm44SlhNNmhjVTh2VHVmMU41a19CU1ZoM0I4TXJKenpRU1ItaldBVjgyOFRYOVd1ZlltZEx1ZjgtRnY2VVBuR1VlbEd4UWFDRHh2U0NLTHJrRWVCS3ktOHVuTk05bkk?oc=5","date":"2023-06-22","type":"pipeline","source":"MassDevice","summary":"Integra Lifesciences names Lea Daniels Knight as CFO - MassDevice","headline":"Integra Lifesciences names Lea Daniels Knight as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNa01SS3RpZlRURG5zcGdWOU51TEtUX24zZWd4aVZXcFplcWgtY0hMdnFFa2pwR0MyUzRFR0NXNlVpSm1vcE5wVWtkME1vbkJFX2U2SmxZR0NmOTZqSFBoYzE1MDMwOVdOclZ5QTljenB2QlJnaDlRTm9QUnV5ZWlfdw?oc=5","date":"2020-04-30","type":"pipeline","source":"MarketBeat","summary":"Top Integra LifeSciences (IART) Competitors 2026 - MarketBeat","headline":"Top Integra LifeSciences (IART) Competitors 2026","sentiment":"neutral"}],"patents":[{"drugName":"DuraGen Dural Regeneration Matrix","drugSlug":"duragen","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Stryker","Medtronic","Johnson & Johnson"],"therapeuticFocus":["Regenerative Medicine","Neurosurgery"],"financials":{"source":"sec_edgar","revenue":1635245000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":1635245000,"period":"2025-12-31"},{"value":1610527000,"period":"2024-12-31"},{"value":1610527000,"period":"2024-12-31"},{"value":1541573000,"period":"2023-12-31"},{"value":1541573000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":78041000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-516474000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":3602001000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":9.94,"previousClose":9.33,"fiftyTwoWeekHigh":20.55,"fiftyTwoWeekLow":8.7,"fiftyTwoWeekRange":"8.7 - 20.55","fiftyDayAverage":10.41,"twoHundredDayAverage":12.61,"beta":1.06,"enterpriseValue":2498226176,"forwardPE":3.9,"priceToBook":0.74,"priceToSales":0.47,"enterpriseToRevenue":1.53,"enterpriseToEbitda":8.39,"pegRatio":0.67,"ebitda":297747008,"ebitdaMargin":18.2,"freeCashflow":44463500,"operatingCashflow":50384000,"totalDebt":2034813056,"debtToEquity":195,"currentRatio":2.54,"returnOnAssets":2.4,"returnOnEquity":-39.9,"analystRating":"","recommendationKey":"none","numberOfAnalysts":7,"targetMeanPrice":15.57,"targetHighPrice":25,"targetLowPrice":9,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":13.9,"institutionHeldPercent":98,"sharesOutstanding":77937208,"floatShares":58961057,"sharesShort":8359840,"shortRatio":10.38,"shortPercentOfFloat":10.7,"epsTrailing":-6.74,"epsForward":2.56,"revenuePerShare":21.33,"bookValue":13.4,"officers":[{"age":52,"name":"Ms. Lea Daniels Knight","title":"Executive VP & CFO"},{"age":66,"name":"Mr. Robert T. Davis Jr.","title":"Executive VP & President of Tissue Technologies"},{"age":58,"name":"Mr. Michael J. McBreen","title":"Executive VP & President of Codman Specialty Surgical"},{"age":59,"name":"Mr. Harvinder Pal Singh","title":"Executive VP & President of International Business"},{"age":62,"name":"Ms. Mojdeh  Poul","title":"President, CEO & Director"},{"age":49,"name":"Mr. Jeffrey A. Mosebrook","title":"Senior VP of Finance & Principal Accounting Officer"},{"age":null,"name":"Mr. Teshtar  Elavia","title":"Corporate VP & Chief Technology Officer"},{"age":null,"name":"Christopher  Ward","title":"Senior Director of Investor Relations"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.integralife.com","phone":"609 275 0500"}}